We have shown that activated STAT3 and activated TrkA can be found in triple-negative and HER2-enriched breast cancers and that the combined JAK2–STAT3/TrkA activation signatures are significantly enriched in these two subtypes (Figure 1). Here, JAK2 is linked to breast carcinoma.